Internal Medicine, Hematology · Brick, NJ
NPI
1720071731
Since 2005
Specialty
Internal Medicine, Hematology
Code 207RH0000X
Group practices
3
Medicare group memberships
Hospitals
4
Hospital affiliations
525 Jack Martin Blvd Ste 201
Brick, NJ, 08724
Phone (732) 840-8880
Groups this clinician bills Medicare through
Medicare paid, 2024
$4.0M
312,259 services
Medicare patients, 2024
1,130
Average age 76
Drug cost, 2024
$7.4M
1,970 prescriptions
Company payments, 2025
$752
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Girish S Amin was code J1439 (injection, ferric carboxymaltose, 1 mg), 79,500 times for 59 patients. In total Girish S Amin billed 312,259 services in 131 codes, and Medicare paid $4.0M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-09-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 79,500 | 59 | $0.87 | $69K |
| J1756 Injection, iron sucrose, 1 mg | Office | 29,200 | 45 | $0.17 | $4,954 |
| Q5125 Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram | Office | 19,200 | 13 | $0.38 | $7,370 |
| J9271 Injection, pembrolizumab, 1 mg | Office | 18,200 | 25 | $44.82 | $816K |
| J1453 Injection, fosaprepitant, 1 mg | Office | 10,800 | 22 | $0.11 | $1,201 |
| J0897 Injection, denosumab, 1 mg | Office | 9,540 | 42 | $20.65 | $197K |
| J1306 Injection, inclisiran, 1 mg | Office | 7,952 | 24 | $9.55 | $76K |
| J0185 Injection, aprepitant, 1 mg | Office | 5,590 | 14 | $1.34 | $7,507 |
| J1449 Injection, eflapegrastim-xnst, 0.1 mg | Office | 4,224 | 14 | $20.84 | $88K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 4,150 | 68 | $0.09 | $367 |
| 36415 Venipuncture Blood Collection | Office | 3,157 | 864 | $8.65 | $27K |
| 85025 Blood Count | Office | 2,990 | 841 | $7.60 | $23K |
| J1626 Injection, granisetron hydrochloride, 100 mcg | Office | 2,705 | 52 | $0.25 | $669 |
| Q5106 Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | Office | 2,590 | 25 | $5.65 | $15K |
| 99214 Office E&M - Established | Office | 1,361 | 623 | $107.33 | $146K |
By year: 2022 $3.1M for 252,810 services; 2023 $2.3M for 202,690 services; 2024 $4.0M for 312,259 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 3,157 | 864 | $8.65 | $27K |
| 85025 Blood Count | 2,990 | 841 | $7.60 | $23K |
Medicare prescription drug claims, 2024
In 2024, the drug Girish S Amin prescribed most often to Medicare patients was Hydroxyurea, with 150 prescriptions and refills. In total Girish S Amin wrote 1,970 Medicare prescriptions that cost $7.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxyurea Generic | 150 | 324 | 47 | $3,709 |
| Prednisone Generic | 118 | 157 | 46 | $714 |
| Letrozole Generic | 103 | 272 | 36 | $2,285 |
| Eliquis Apixaban | 90 | 122 | 24 | $70K |
| Ondansetron Hcl Generic | 82 | 82 | 50 | $711 |
| Jakafi Ruxolitinib Phosphate | 82 | 82 | 11 | $1.4M |
| Abiraterone Acetate Generic | 81 | 81 | 11 | $244K |
| Acyclovir Generic | 76 | 143 | 22 | $1,088 |
| Allopurinol Generic | 44 | 72 | 14 | $244 |
| Gabapentin Generic | 37 | 46 | Under 11 | $516 |
| Brukinsa Zanubrutinib | 37 | 37 | Under 11 | $516K |
| Warfarin Sodium Generic | 36 | 75 | Under 11 | $203 |
| Dexamethasone Generic | 34 | 45 | 20 | $622 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 31 | 31 | 22 | $307 |
| Oxycodone Hcl Generic | 31 | 31 | 19 | $411 |
Brand drugs: - claims; generic drugs: 1,430 claims; opioid claims: 82.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Girish S Amin $752 ($752 in general payments such as food, travel and fees) from 22 companies. The largest payer was Gilead Sciences, Inc. with $202.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 10 | $202 |
| Daiichi Sankyo Inc. 4568.T | 7 | $158 |
| Pharmacosmos Therapeutics Inc. | 2 | $37.54 |
| Telix Pharmaceuticals TLX | 2 | $34.51 |
| Geron Corporation GERN | 2 | $33.05 |
| Regeneron Healthcare Solutions, Inc. REGN | 2 | $32.99 |
| Aveo Pharmaceuticals, Inc. | 1 | $28.12 |
| Genzyme Corporation SNY | 1 | $22.63 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $21.31 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 1 | $18.99 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.